Business Context and Reporting Period
Company: Benchmark Electronics, Inc. (BHE)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended March 31, 2026
Business Overview: Benchmark provides advanced manufacturing, design, and engineering services to OEMs in the aerospace & defense, medical, industrial, semiconductor capital equipment, and advanced computing sectors. Operations are conducted across the Americas, Asia, and Europe.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Sales | $677.3 million | $631.8 million |
| Gross Profit | $69.2 million | $63.2 million |
| Gross Margin | 10.2% | 10.0% |
| Income from Operations | $21.9 million | $11.8 million |
| Net Income | $13.0 million | $3.6 million |
| Diluted EPS | $0.36 | $0.10 |
| Operating Cash Flow | $47.0 million | $31.5 million |
| Cash & Equivalents | $325.2 million | $355.3 million |
| Total Debt (Gross) | $207.2 million | $210.6 million |
| Available Credit | $486.0 million | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 7% year-over-year, driven by a 41% surge in Advanced Computing & Communications (AC&C) and a 24% increase in Medical sectors. These gains offset declines in Semi-Cap (-2%), Industrial (-3%), and Aerospace & Defense (-2%).
- Profitability Expansion: Net income increased 257% to $13.0 million. Operating income rose 86% to $21.9 million, primarily due to a significant reduction in restructuring and other costs compared to Q1 2025, which included a $10.1 million tax assessment settlement.
- Segment Performance: The Americas segment turned a loss of $4.4 million in Q1 2025 into a profit of $7.8 million in Q1 2026. Asia segment operating income grew 8% to $41.9 million.
- Effective Tax Rate: The effective tax rate decreased to 29.3% from 56.6% in the prior year, as the prior period was impacted by losses in jurisdictions where no tax benefit was recognized.
Outlook, Risks, and Management Commentary
- Capital Expenditures: Management expects capital expenditures to approximate $70 million to $80 million over the next 12 months to support production capacity and revenue growth.
- Restructuring: The company recognized $3.7 million in restructuring charges in Q1 2026, primarily related to the planned closure of a site in Phoenix, Arizona, and workforce reductions.
- Shareholder Returns: The company repurchased 0.1 million shares for $5.8 million and declared a quarterly dividend of $0.17 per share. $116.9 million remains available under the share repurchase authorization.
- Risks & Contingencies:
- Legal Proceedings: An arbitration action is ongoing against CommScope Holding Company regarding excess and obsolete inventory. The dispute is in initial stages with no discovery conducted.
- Geopolitical & Trade: The company is monitoring the impact of recent U.S. Supreme Court rulings on tariffs and potential refunds, though no material impact has been recorded.
- Supply Chain: Fluctuations in component availability and pricing continue to pose risks, though supply conditions have improved in certain areas.
Investor Verification Checklist
- Revenue Mix Sustainability: Verify the durability of the 41% growth in the AC&C sector and 24% growth in Medical, which drove the overall revenue increase.
- Restructuring Execution: Monitor the progress and cost implications of the Phoenix site closure and other capacity realignment initiatives.
- Legal Exposure: Track the status of the CommScope arbitration regarding excess inventory claims.
- Working Capital Trends: Review the $25.6 million increase in inventories and the $8.1 million increase in contract assets to ensure they align with order backlogs and do not signal obsolescence risks.
- Debt Covenants: Confirm continued compliance with interest coverage and debt leverage covenants under the $700 million credit agreement.